CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE trials appear
Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug hope to stop dangerous transplant complication in kids
Disease control OngoingThis study is testing if adding a drug called vorinostat to standard medications can better prevent graft-versus-host disease (GVHD) in children and young adults getting a bone marrow transplant for blood cancers. GVHD is a serious complication where the donor's immune cells atta…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for leukemia patients after first treatment fails
Disease control OngoingThis study is testing a drug called asciminib for adults with chronic phase chronic myeloid leukemia (CML). It includes two groups: patients whose first treatment didn't work well or caused side effects, and newly diagnosed patients. The goal is to see if asciminib can effectivel…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC